At the end of 2025, the European Union advanced significant initiatives aimed at modernising and strengthening the regulatory framework for the life sciences sector. From the political agreement on the pharmaceutical package...more
2/5/2026
/ Biotechnology ,
EU ,
Healthcare ,
Innovation ,
Life Sciences ,
Medical Devices ,
New Legislation ,
Pharmaceutical Industry ,
Regulatory Oversight ,
Regulatory Reform ,
Regulatory Requirements